Skip to content

The efficacy and safety of 755 nm picosecond laser for the treatment of lip hyperpigmentation in asians: a pilot study

The efficacy and safety of 755 nm picosecond laser for the treatment of lip hyperpigmentation in asians: a pilot study

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
TCTR
Registry ID
TCTR20210129006
Enrollment
20
Registered
2021-01-29
Start date
2018-11-22
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Minimal local side effects such as redness, swollen and skin irritation may occur. These could be resolved within a few days. Local side effect

Interventions

Non ablative laser
Experimental Device
755 nm picosecond laser

Sponsors

Department of Dermatology, Faculty of Medicine Siriraj Hospital, Mahidol University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
25 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1.Lip darkening, 2.Healthy status

Exclusion criteria

Exclusion criteria: 1.Pregnancy or lactation, 2.Photosensitivity disorder or skin disease at the perioral area; for example, acne, chelitis, herpes simplex infection, etc., 3.Skin lesion suspected malignancy, 4.Immunocompromised status, 5.History of the perioral procedure during the last 3 months; for example, botulinum toxin injection, filler injection, chemical peeling, etc., 6.History of hypertrophic scar or keloids, 7.History of pigmentation disorder; for example, freckle, lentigines, seborrheic keratosis, etc.

Design outcomes

Primary

MeasureTime frame
Melanin index Baseline, 1,3,6-month after 5 sessions Antera 3D (Miravex, Dublin 2, Ireland)

Secondary

MeasureTime frame
Physician grading scale 1 month after 5 sessions Quartile scale,Patient satisfaction assessment 1,3,6 months after 5 sessions Quartile scale,Adverse effect immediate to 2 weeks after each session, 1,3,6 months after 5 sessions observation

Countries

Thailand

Contacts

Public ContactWoraphong Manuskiatti

Mahidol University

woraphong.man@mahidol.ac.th024194333

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026